PQS names John Michael O’Brien to board of directors
Pharmacy performance management service provider Pharmacy Quality Solutions has added a prominent name to its board of directors' roster. John Michael O’Brien, former senior advisor to the secretary for drug pricing reform at the Department of Health and Human Services has joined PQS' board of directors, effective Aug. 4.
O’Brien brings his expertise in Centers for Medicare and Medicaid Services, HHS, the White House, and Congressional policy development, as well as expertise in payment, quality and prescription drug policy.
“We are pleased to welcome John to the PQS board of directors,' said Jeff Newel, PQS CEO.We will utilize his vast expertise, knowledge and leadership skills as an executive in government health policy to further our organizational mission to assist both plans and providers to improve the health status of their patients."
Menighan, PQS’ current chairperson, said, “John’s lifetime work embodies the principles of quality on which PQS was founded. His perspectives and guidance promise to help us expand measurable quality patient care with our partners. It is an honor to work directly with Dr. O’Brien and see the next chapter of growth for PQS.”
In addition to his role at HHS as senior advisor to the secretary for drug pricing reform, O’Brien, who is a pharmacist, led policy development on multiple administration priorities, including improving the affordability and access of prescription drugs.
He also served as deputy assistant secretary of health policy for planning and evaluation, and a key advisor to the secretary for health policy research, development, and analysis related to Medicare, Medicaid, and private health insurance.
He is a certified health insurance executive, held senior policy positions in the life sciences and managed care industries, was a career official at CMS during the Obama administration and served as a health policy fellow in the U.S. Senate. He also holds a number of academic appointments, a master’s degree in public health from the Johns Hopkins Bloomberg School of Public Health, a doctor of pharmacy degree from Nova Southeastern University, and studied pharmacy and public policy at the University of Florida.